COMPANY PROFILE · /lunit
L
Lunit
Lunit develops AI-powered medical imaging software for cancer screening and treatment, with a focus on breast cancer detection and lung cancer analysis. The company is publicly traded (KOSDAQ: 328130) and has raised $561M+ across multiple rounds.
Fresh · 5d ago
Latest valuation
—
Annual Recurring Revenue
—
Headcount
—
Funding total
$561.1M
OVERVIEW
Publicly listed medtech AI company. Lunit's mammography AI achieved +13% cancer detection improvement in dense breasts (Lancet Digital Health 2020). Deployed in hospitals across Asia, Europe, and North America.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.